Comparison between Aptus Pharma IPO and Purple Wave Infocom IPO.
Aptus Pharma IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Purple Wave Infocom IPO is a SME Bookbuilding proposed to list at BSE SME.
| Aptus Pharma IPO | Purple Wave Infocom IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Interactive Financial Services Ltd. | Smart Horizon Capital Advisors Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Maashitla Securities Pvt.Ltd. |
| Market Maker | Market-Hub Stock Broking Pvt.Ltd. | Shreni Shares Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Aptus Pharma IPO is up to ₹12.36 Cr whereas the issue size of the Purple Wave Infocom IPO is up to ₹29.84 Cr. The final issue price of Aptus Pharma IPO is ₹70.00 per share and of Purple Wave Infocom IPO is ₹126.00 per share.
| Aptus Pharma IPO | Purple Wave Infocom IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹65.00 per share | ₹120.00 per share |
| Issue Price (Upper) | ₹70.00 per share | ₹126.00 per share |
| Issue Price (Final) | ₹70.00 per share | ₹126.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 1000 shares |
| Fresh Issue Size | 17,66,000 shares | 23,68,000 shares |
| Fresh Issue Size (Amount) | up to ₹12.36 Cr | up to ₹29.84 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 17,66,000 shares | 23,68,000 shares |
| Issue Size Total (Amount) | up to ₹12.36 Cr | up to ₹29.84 Cr |
Aptus Pharma IPO opens on Sep 23, 2025, while Purple Wave Infocom IPO opens on Nov 28, 2025. The closing date of Aptus Pharma IPO and Purple Wave Infocom IPO is Sep 25, 2025, and Dec 02, 2025, respectively.
| Aptus Pharma IPO | Purple Wave Infocom IPO | |
|---|---|---|
| Anchor Bid Date | Sep 22, 2025 | Nov 27, 2025 |
| Issue Open | Sep 23, 2025 | Nov 28, 2025 |
| Issue Close | Sep 25, 2025 | Dec 02, 2025 |
| Basis Of Allotment (Tentative) | Sep 26, 2025 | Dec 03, 2025 |
| Initiation of Refunds (Tentative) | Sep 29, 2025 | Dec 04, 2025 |
| Credit of Share (Tentative) | Sep 29, 2025 | Dec 04, 2025 |
| Listing date (Tentative) | Sep 30, 2025 | Dec 05, 2025 |
| Anchor Lockin End date 1 | Oct 26, 2025 | Jan 03, 2026 |
| Anchor Lockin End date 2 | Dec 25, 2025 | Mar 04, 2026 |
Aptus Pharma IPO P/E ratio is 11.29, as compared to Purple Wave Infocom IPO P/E ratio of 9.33.
| Aptus Pharma IPO | Purple Wave Infocom IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Aptus Pharma Ltd.'s revenue increased by 38% and profit after tax (PAT) rose by 288% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)Purple Wave Infocom Ltd.'s revenue increased by 40% and profit after tax (PAT) rose by 68% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 98.52 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 72.89 | 71.92 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 11.29 | 9.33 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹48.02 Cr. | ₹116.50 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 44.50% | 71.54% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 45.66% | 42.80% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.49 | 0.85 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹6.20 | ₹13.50 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 44.50% | 52.69% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Aptus Pharma IPO Retail Individual Investors (RII) are offered 6,20,000 shares while in Purple Wave Infocom IPO retail investors are offered 6,20,000 shares. Qualified Institutional Buyers (QIB) are offered 3,52,000 shares in Aptus Pharma IPO and 4,80,000 shares in Purple Wave Infocom IPO.
| Aptus Pharma IPO | Purple Wave Infocom IPO | |
|---|---|---|
| Anchor Investor Reservation | 5,28,000 shares | 6,34,000 shares |
| Market Maker Reservation | 94,000 shares | 1,28,000 shares |
| QIB | 3,52,000 shares | 4,80,000 shares |
| NII | 2,66,000 shares | 3,78,000 shares |
| RII | 6,20,000 shares | 8,76,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 17,66,000 shares | 23,68,000 shares |
Aptus Pharma IPO subscribed 22.27x in total, whereas Purple Wave Infocom IPO subscribed 6.88x.
| Aptus Pharma IPO | Purple Wave Infocom IPO | |
|---|---|---|
| QIB (times) | 1.24x | 11.85x |
| NII (times) | 28.75x | 7.69x |
| Big NII (times) | 30.64x | 8.87x |
| Small NII (times) | 24.93x | 5.32x |
| RII (times) | 31.43x | 3.80x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 22.27x | 6.88x |
